Wordt geladen...
Biomarkers for Immune Checkpoint Inhibitors in Melanoma
Immune checkpoint inhibitors have now become a standard therapy for malignant melanoma. However, as immunotherapies are effective in only a limited number of patients, biomarker development remains one of the most important clinical challenges. Biomarkers predicting clinical benefit facilitate appro...
Bewaard in:
| Gepubliceerd in: | Front Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058029/ https://ncbi.nlm.nih.gov/pubmed/30073150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00270 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|